THE TAPE
COR · Drug Wholesalers · $68.1B

Cencora, Inc.

$356.94▼ −0.58%
Last close
Relative strength
71RS
of 99, against every stock▲ +10 on the month
Powering up
Unconfirmed
+36.1%
six months against the S&P 500
52-week range
−5.5%
from the high
$244.82$377.54
Setup
flat baseclimbing
+5.4%
against the pivot at $338.71
No report date on the calendar.
Growth FLATProof SHOWN
Quarter to Jun 30, revenue +5% on a year ago
11/16 O 362.59 H 363.50 L 355.90 Vol 1.2M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

RS71
vs pivot+5.38%
Tightening0.88×
Dry-up1.08×
Up/down vol-0.06
From high5%
climbing5 of 9checks
Powering up
Support and resistance
Support below
$333.52
-6.6% · tested 4× · last 6 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 5.8 weeks and fell 13% from its ceiling at its deepest. The pivot is $338.71, and the stock closed 5.4% above that pivot. Its relative strength rating is 71.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+8.0%
Three months against the S&P 500
+17.1%
Six months against the S&P 500
+36.1%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same industry
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 4.9% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$332.8B
+5.1% year on year
Operating margin
0.9%
gross 4.0%
Net margin
0.8%
Free cash flow
$4.1B
6.0% of market cap
Price to sales
0.20×
Price to earnings
25.9×

Twelve months to Jun 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 4

The prior quarter: the 10-Q for this report is not filed yet.

Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$84.8B
+8.2% QoQ · +5.1% YoY
Gross margin
4.3%
-0.3 pts QoQ
Net income
$763.5M
Positive
Free cash flow
$2.4B
Cash generating

What the numbers say

  • Revenue +5.1% year over year, +8.2% on the quarter
  • Gross margin 4.3%, -0.3 points on the quarter
  • Good: Profitable: net income $764M, operating margin 1.3%
  • Good: Cash generating: operating cash flow $2.65B, free cash flow $2.43B
  • Net debt $8.91B · cash $2.82B
Revenue by quarter
Free cash flow
Net income
shares -0.7% in a year · net debt $8.9B
Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 2 of 46 tracked funds at the end of Q3 2026.

Last quarter: 2 added.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Red flag in a filingFiling · 2026-11-05
dismissal of
No measurable effect: stocks behave like random ones over the next three sessions (1,160 cases over 54 nights).
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-05
above 20d & 50d on 2.3x volume at 354.00
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
Unusual volumeTape · 2026-11-05
5.3 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Earnings comingEvent · 2026-11-03
reports 2026-11-04 bmo
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).
Reported resultsFiling · 2026-10-22
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
A director or officer changedFiling · 2026-09-26
5.02
No measurable effect: stocks behave like random ones over the next three sessions (1,288 cases over 54 nights).
Unusual volumeTape · 2026-09-19
4.0 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders
Bought on the open market
3
$2,310,427 total
Sold on the open market
5
$5,020,270 total

Bought: Tyler Lauren M, DURCAN DERMOT MARK. Sold: Krikorian Lazarus, GREENBERG LON R, Campbell Elizabeth S.

Not counted above: 31 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-11-12 Mauch Robert P. · President & CEO, Directoroption exercise4,682
2026-11-12 Mauch Robert P. · President & CEO, Directorwithheld for tax1,927$673,255
2026-11-12 Krikorian Lazarus · SVP & Chief Accounting Officeroption exercise666
2026-11-12 Krikorian Lazarus · SVP & Chief Accounting Officerwithheld for tax274$95,730
2026-11-12 Campbell Elizabeth S · Executive Vice Presidentoption exercise1,174
2026-11-12 Campbell Elizabeth S · Executive Vice Presidentwithheld for tax543$189,713
2026-11-12 Verma Pawan · EVP, Chief Data & Info Officeroption exercise1,321
2026-11-12 Verma Pawan · EVP, Chief Data & Info Officerwithheld for tax676$236,181

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What lines up

5 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy3
Buy7
Hold4
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

Checking your subscription…

X-ray
6w · 13%

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Cencora, Inc. (COR) — The Tape